First approval for hep C contender simeprevir, in Japan
This article was originally published in Scrip
Executive Summary
It seems that Japan's Pharmaceuticals and Medical Devices Agency (PMDA) is taking concrete actions to back up its stated goal of being the first in the world to approve new products in the fields it regulates.